Madrid, Spain

Lluis Ballell

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lluis Ballell. Retrieved from https://idiyas.com/inventor/lluis-ballell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lluis Ballell: A Pioneer in Antibacterial Compounds

Introduction: Lluis Ballell, an innovative inventor based in Madrid, Spain, has made significant contributions to the field of antibacterial research. With a focus on improving health through advancements in medicinal chemistry, Ballell’s work has culminated in a notable patent that showcases his expertise in creating effective pharmaceutical compounds.

Latest Patents: Lluis Ballell holds a patent for "Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones - Bicyclic nitrogen-containing compounds and their use as antibacterials." This patent highlights the development of novel compounds that possess antibacterial properties, addressing critical health needs in combating bacterial infections.

Career Highlights: Throughout his career, Ballell has been associated with Glaxo Group Limited, a prominent player in the pharmaceutical industry. His work focuses on the discovery and development of new compounds that can potentially improve the effectiveness of treatments for bacterial infections.

Collaborations: In his professional journey, Ballell has collaborated with notable colleagues including David Barros and Gerald Brooks. These collaborations have helped foster a dynamic research environment, enhancing the potential for innovative discoveries in medicinal chemistry.

Conclusion: Lluis Ballell represents the forefront of innovation in antibacterial research. With a strong foundation in medicinal compounds and a commitment to improving health outcomes, his contributions continue to be invaluable in the fight against bacterial infections. As he advances in his career, Ballell's work is expected to yield further breakthroughs in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…